Coeptis Therapeutics, Inc. (COEP) has a market capitalization of $45.64M and trades at $12.99. The 52-week range is 6.26-21.41.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.6, Earnings Per Share (EPS) of $-2.81, annual revenue of $1.36M.
The stock has a beta of -0.43, operates in the Healthcare sector.